[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Page 15044]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07336]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) Notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Joseph Duran, Director of Policy and
Planning, Office of Community Care, Veterans Health Administration,
Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC
20420; email: [email protected]; telephone: (303) 372-4629 (this is
not a toll-free number).
SUPPLEMENTARY INFORMATION: Section 17.110 of Title 38 CFR governs
copayments for medications that VA provides to Veterans. Section 17.110
provides the methodologies for establishing the copayment amount for
each 30-day or less supply of medication provided by VA on an
outpatient basis (other than medication administered during treatment).
Section 17.110 provides a list of Tier 1 medications that will be
published as a Notice in the Federal Register and will be posted on
VA's website (www.va.gov/health) at least once per year. Tier 1
medication means a multi-source medication that has been identified
using the process described in Section 17.110(b)(2). 38 CFR Section
17.110(b)(1)(iv)(B). Based on the methodologies set forth in Section
17.110, this Notice updates the list of Tier 1 medications.
Not less than once per year, VA will identify a subset of multi-
source medications as Tier 1 medications. Only medications that meet
all of the criteria in paragraphs (b)(2)(i), (ii), and (iii) of Section
17.110 will be eligible to be considered Tier 1 medications, and only
those medications that meet all of the criteria in paragraph (b)(2)(i)
of this section will be assessed using the criteria in paragraphs
(b)(2)(ii) and (iii). As of the date of this Notice, the Tier 1
medication list based on the methodologies in Section 17.110 will be
posted on VA's website (www.va.gov/health) under the heading ``Tier 1
Copay Medication List.''
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2019, and will remain in effect until December 31,
2019.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain........... Aspirin Buffered Tablet, Aspirin Chewable
Tablet, Aspirin Enteric Coated Tablet,
Allopurinol Tablet, Ibuprofen Tablet,
Meloxicam Tablet, Naproxen Tablet.
Blood Thinners and Platelet Clopidogrel Bisulfate Tablet, Warfarin
Inhibitors. Sodium Tablet.
Bone Health.................. Alendronate Tablet.
Cholesterol.................. Atorvastatin Tablet, Gemfibrozil Tablet,
Lovastatin Tablet, Niacin (Slo-Niacin)
Tablet, Pravastatin Tablet, Rosuvastatin
Calcium Tablet, Simvastatin Tablet.
Dementia..................... Donepezil Tablet, Memantine Hydrochloride
(HCL) Tablet.
Diabetes..................... Glipizide Tablet, Metformin HCL Tablet,
Metformin HCL 24-hour (HR) Sustained
Action (SA) Tablet, Pioglitazone HCL
Tablet.
Electrolyte Supplement....... Potassium SA Tablet, Potassium SA
Dispersible Tablet.
Gastrointestinal Health...... Omeprazole Enteric Coated (EC) Capsule,
Pantoprazole Sodium EC Capsule,
Ranitidine Tablet.
Glaucoma and Eye Care........ Brimonidine 0.2% Solution, Dorzolamide 2%/
Timolol 0.5% Solution, Latanoprost
0.005% Solution, Timolol Maleate 0.25%
Solution, Timolol Maleate 0.5% Solution.
Heart Health and Blood Amlodipine Tablet, Amiodarone HCL Tablet,
Pressure. Aspirin (see Arthritis and Pain),
Atenolol Tablet, Carvedilol Tablet,
Chlorthalidone Tablet, Clonidine Tablet,
Diltiazem 24-Hour Capsule, Diltiazem HCL
Tablet, Enalapril Maleate Tablet,
Furosemide Tablet, Hydrochlorothiazide
Capsule/Tablet, Hydrochlorothiazide/
Lisinopril Tablet, Hydrochlorothiazide/
Triamteren Capsule/Tablet, Isosorbide
Mononitrate SA Tablet, Lisinopril
Tablet, Losartan Tablet, Metoprolol
Succinate SA Tablet, Metoprolol Tartrate
Tablet, Nifedipine SA Capsule,
Nitroglycerin Sublingual Tablet,
Prazosin HCL Capsule, Propranolol HCL
Tablet, Spironolactone Tablet, Valsartan
Tablet, Verapamil HCL Tablet, Verapamil
HCL SA Tablet.
Mental Health................ Amitriptyline HCL Tablet, Bupropion HCL
Tablet, Bupropion HCL SA (12-HR
Sustained Release) Tablet, Bupropion HCL
SA (24-HR Extended Release XL) Tablet,
Buspirone HCL Tablet, Citalopram
Hydrobromide Tablet, Duloxetine HCL EC
Capsule, Escitalopram Oxalate Tablet,
Fluoxetine Capsule/Tablet, Lithium
Carbonate Capsule/Tablet, Mirtazapine
Tablet, Paroxetine HCL Tablet,
Sertraline HCL Tablet, Trazodone Tablet,
Venlafaxine HCL Tablet, Venlafaxine HCL
SA Tablet/Capsule.
Respiratory Condition........ Montelukast NA Tablet.
Seizures..................... Gabapentin Capsule, Lamotrigine Tablet,
Topiramate Tablet.
Thyroid Conditions........... Levothyroxine Sodium Tablet.
Urologic (Bladder and Alfuzosin HCL SA Tablet, Doxazosin
Prostate) Health. Mesylate Tablet, Finasteride Tablet,
Oxybutynin Chloride Tablet, Oxybutynin
Chloride SA Tablet, Tamsulosin HCL
Capsule, Terazosin HCL Capsule.
------------------------------------------------------------------------
Signing Authority
The Secretary of Veterans Affairs, or designee, approved this
document and authorized the undersigned to sign and submit the document
to the Office of the Federal Register for publication electronically as
an official document of the Department of Veterans Affairs. Robert L.
Wilkie, Secretary, Department of Veterans Affairs, approved this
document on March 14, 2019, for publication.
Dated: April 9, 2019.
Luvenia Potts,
Program Specialist, Office of Regulation Policy & Management, Office of
the Secretary, Department of Veterans Affairs.
[FR Doc. 2019-07336 Filed 4-11-19; 8:45 am]
BILLING CODE 8320-01-P